American Biotech Firm Axiom Biosciences to List in Hong Kong Before Wall Street

July 22, 2026 — 08:15 CST

This Data Is Locked!

This area is available only to Subscribers.

Based in San Diego, Axiom Biosciences is set to seek a primary listing in Hong Kong in 2027, followed by a secondary U.S. listing in... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Related Data:

Zhibao Technology’s Plans to Acquire 3,500 Bitcoin in Nasdaq PIPE Financing Deal

July 23, 2026 — 05:40

Chinese Optical Parts Maker Zhongji Innolight Seeks Record IPO in Hong Kong

July 22, 2026 — 20:30

Chinese Investors Eye Hong Kong and US Amid Regulatory Crackdown

July 22, 2026 — 20:30

Hong Kong’s Asset Management Sector Set to Boom Following Tax Reforms: KPMG Report

July 22, 2026 — 14:25

Europe’s Citric Acid Industry Faces Existential Threat from Chinese Competition

July 22, 2026 — 14:25

Intelligent Energy Expands Hydrogen UAV Technology in China’s Growing Low-Altitude Sector

July 22, 2026 — 11:20

China’s GigaAI Leads World Model AI Startups in Race to IPO

July 21, 2026 — 13:55

Chinese Stocks Gain as State-Backed Insurers Advocate Long-Term Investments

July 21, 2026 — 10:50

Moonshot’s Kimi K3 AI Model Disrupts Market Dynamics in China

July 20, 2026 — 22:25